Balayan, T., Horvath, H., & Rutherford, G. W. (2017). Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review. AIDS Res Treat.
Chicago-стиль цитированияBalayan, Tatevik, Hacsi Horvath, and George W. Rutherford. "Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors Versus Other Regimens for Initial Antiretroviral Therapy for People With HIV Infection: A Systematic Review." AIDS Res Treat 2017.
MLA-цитированиеBalayan, Tatevik, Hacsi Horvath, and George W. Rutherford. "Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors Versus Other Regimens for Initial Antiretroviral Therapy for People With HIV Infection: A Systematic Review." AIDS Res Treat 2017.